37 results for "Martin Posch"
Showing 1–20 · 3.08 seconds · RSS
-
Journal Article
Impact of adaptive filtering on power and false discovery rate in RNA-seq experiments
Abstract Background In RNA-sequencing studies a large number of hypothesis tests are performed to compare the differential expression of genes between several conditions. Filtering has been proposed to remove candidate genes with a low expression level which may not be relevant and have little or…
-
Journal Article
Evaluation of the Fill-it-up-design to use historical control data in randomized clinical trials with two arm parallel group design
Abstract Purpose In the context of clinical research, there is an increasing need for new study designs that help to incorporate already available data. With the help of historical controls, the existing information can be utilized to support the new study design, but of course, inclusion also…
-
Journal Article
Comparison of primary analysis strategies of randomized controlled trials with multiple endpoints with application to kidney transplantation
Abstract Relying on a single primary endpoint in randomized controlled trials (RCTs) is often infeasible, for example due to rare or heterogeneous events. Regulatory guidance therefore allows multiple endpoints, but different analytical strategies address different scientific questions and null…
-
Journal Article
An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis
Abstract The number of reported coronavirus disease (COVID-19) deaths per 100,000 persons observed so far in 2020 is described in 15 European countries and the USA as dependent on age groups and sex. It is compared with the corresponding historic all-cause mortality per year depending on age and…
-
Journal Article Full text
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials.
Mid-study design modifications are becoming increasingly accepted in confirmatory clinical trials, so long as appropriate methods are applied such that error rates are controlled. It is therefore unfortunate that the important case of time-to-event endpoints is not easily handled by the standard…
Also available at: PLOS
-
Journal Article Full text
Subgroup identification in clinical trials via the predicted individual treatment effect.
Identifying subgroups of treatment responders through the different phases of clinical trials has the potential to increase success in drug development. Recent developments in subgroup analysis consider subgroups that are defined in terms of the predicted individual treatment effect, i.e. the…
Also available at: PLOS
-
Journal Article Full text
Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program.
AimsMass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical…
Also available at: PLOS
-
Journal Article
NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls
Platform trials evaluate the efficacy of multiple treatments, allowing for late entry of the experimental arms and enabling efficiency gains by sharing controls. The power of individual treatment-control comparisons in such trials can be improved by utilizing non-concurrent controls (NCC) in the…
-
Journal Article
On the use of non-concurrent controls in platform trials: a scoping review
Abstract Background Platform trials gained popularity during the last few years as they increase flexibility compared to multi-arm trials by allowing new experimental arms entering when the trial already started. Using a shared control group in platform trials increases the trial efficiency…
-
Journal Article Full text
Optimizing Trial Designs for Targeted Therapies
An important objective in the development of targeted therapies is to identify the populations where the treatment under consideration has positive benefit risk balance. We consider pivotal clinical trials, where the efficacy of a treatment is tested in an overall population and/or in a…
Also available at: DOAJ
-
Journal Article
Factors associated with physician decision making on withholding cardiopulmonary resuscitation in prehospital medicine
Abstract This study seeks to identify factors that are associated with decisions of prehospital physicians to start (continue, if ongoing) or withhold (terminate, if ongoing) CPR in patients with OHCA. We conducted a retrospective study using anonymised data from a prehospital physician response…
-
Journal Article
Value of information methods to design a clinical trial in a small population to optimise a health economic utility function
Abstract Background Most confirmatory randomised controlled clinical trials (RCTs) are designed with specified power, usually 80% or 90%, for a hypothesis test conducted at a given significance level, usually 2.5% for a one-sided test. Approval of the experimental treatment by regulatory agencies…
-
Journal Article
Nationwide analysis of hospital admissions and outcomes of patients with SARS-CoV-2 infection in Austria in 2020 and 2021
Abstract This retrospective study evaluated temporal and regional trends of patient admissions to hospitals, intensive care units (ICU), and intermediate care units (IMCU) as well as outcomes during the COVID-19 pandemic in Austria. We analysed anonymous data from patients admitted to Austrian…
-
Journal Article
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
Abstract Background In recent years, experience on the application of adaptive designs in confirmatory clinical trials has accumulated. Although planning such trials comes at the cost of additional operational complexity, adaptive designs offer the benefit of flexibility to update trial design and…
-
Journal Article
Efficiency of multivariate tests in trials in progressive supranuclear palsy
Abstract Measuring disease progression in clinical trials for testing novel treatments for multifaceted diseases as progressive supranuclear palsy (PSP), remains challenging. In this study we assess a range of statistical approaches to compare outcomes as measured by the items of the progressive…